- Report
- February 2026
- 154 Pages
Global
From €2114EUR$2,250USD£1,763GBP
- Report
- September 2026
- 284 Pages
Global
From €2349EUR$2,500USD£1,959GBP
- Report
- September 2026
- 188 Pages
Global
From €3331EUR$3,545USD£2,778GBP
€3701EUR$3,939USD£3,087GBP
- Report
- January 2026
- 160 Pages
Global
From €2969EUR$3,160USD£2,476GBP
€3711EUR$3,950USD£3,095GBP
- Report
- September 2025
- 286 Pages
Global
From €4650EUR$4,950USD£3,879GBP
- Report
- April 2024
- 132 Pages
Global
From €893EUR$950USD£744GBP
The Lateral Flow Assay Components market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used in the development and manufacture of lateral flow assays, which are rapid, point-of-care tests used to detect the presence of a specific analyte in a sample. These components include test strips, reagents, antibodies, and other materials. The market is driven by the increasing demand for rapid, accurate, and cost-effective diagnostic tests, as well as the growing prevalence of chronic diseases.
The Lateral Flow Assay Components market is highly competitive, with a number of major players. These include Quidel Corporation, Siemens Healthineers, Abbott Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more